How Has the Whole Genome And Exome Sequencing Market Size Evolved in Recent Years?
The whole genome and exome sequencing market has seen considerable growth due to a variety of factors.
• The size of the total genome and exome sequencing market has seen rapid expansion in recent years. The market, which stood at a value of $2.02 billion in 2024, is projected to climb to a size of $2.53 billion in 2025 with a Compound Annual Growth Rate (CAGR) of around 24.8%.
The impressive growth recorded in the historical period can be traced back to factors such as the reduction in sequencing costs, an increase in genetic disorders, clinical use cases, genomic data archives, and advancements in the field of bioinformatics.
What Is The Forecast For The Whole Genome And Exome Sequencing Market Size?
The whole genome and exome sequencing market is expected to maintain its strong growth trajectory in upcoming years.
• It is projected that the market size for whole genome and exome sequencing will experience substantial expansion in the forthcoming years, reaching $6.14 billion in 2029, growing at a compound annual growth rate (CAGR) of 24.9%.
This growth over the forecast span can be linked to factors like initiatives in population genomics, an increasing need for precision medicine, progress in single-cell sequencing, growth in the scope of non-invasive prenatal testing (NIPT), and its application in the research of rare diseases. Key trends predicted during the forecasted timeline include wider clinical adoption, accelerated progress in sequencing technologies, emergence of large-scale genomic studies, the incorporation of artificial intelligence (AI) and machine learning (ML), along with widened applications in the field of oncology.
What Are The Essential Drivers Behind The Growth Of The Whole Genome And Exome Sequencing Market?
The burgeoning interest in customized medical treatment is predicted to fuel the expansion of the whole genome and exome sequencing market going forward. Customized medicine refers to the medical care practice that customizes healthcare decisions and actions to the particularities of every patient, taking into account aspects like genetics, environment, and way of life. Whole genome and exome sequencing aids in customized medicine by providing an all-encompassing examination of a person's genetic structure. This allows health care decisions and actions to be customized based on their distinct genetic, environmental, and lifestyle factors. For instance, the Personalized Medicine Coalition (PMC), a US-based entity that encourages the comprehension and adoption of personalized medicine, projected in October 2022 that in excess of 75,000 genetic testing products and 300 personalized medicines will grace the market in 2022. Moreover, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) gave the green light to 37 new molecular entities (NMEs) in 2022. Of the 35 therapeutic NMEs, nearly 34%, amounting to 12, fall under the personalized category. As a consequence, the growing demand for personalized medicine is acting as a catalyst for the growth of the whole genome and exome sequencing market.
How Is The Global Whole Genome And Exome Sequencing Market Divided Into Key Segments?
The whole genome and exome sequencing market covered in this report is segmented –
1) By Product Type: Kits, Instruments
2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications
4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits
2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems
Pre-Book The Whole Genome And Exome Sequencing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Whole Genome And Exome Sequencing Market?
Leading companies in the whole genome and exome sequencing markets are shifting their efforts to create cutting-edge technological systems, like ultra-fast NGS (next-generation sequencing) analysis, to stand out in the market. This new technology allows the processing of next-generation sequencing (NGS) data at an unprecedented pace, drastically cutting down on the time needed for genomic data analysis. To demonstrate, in January 2023, QIAGEN Digital Insights (QDI), a bioinformatics firm in the US, unveiled their ultra-fast NGS analysis platform. This platform boasts capabilities such as completing a whole genome process in 25 minutes at a cloud computing cost of $1, thus encouraging efficiency, cost-effectiveness, and scalability. This technological breakthrough significantly improves the speed and availability of genomic data analysis, making it particularly valuable in the whole genome and exome sequencing market by facilitating prompt decision-making and broader implementation of personalized medicine.
Who Are the Key Players In The Whole Genome And Exome Sequencing Market?
Major companies operating in the whole genome and exome sequencing market report are:
• Siemens AG
• Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Cytiva (Danaher Corporation)
• Laboratory Corporation of America Holdings (Labcorp)
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Illumina Inc.
• Canon Medical Systems Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN N.V
• Neusoft Corporation
• BGI Genomics
• Mirion Technologies (Capintec) Inc.
• Novogene Co.
• Oxford Nanopore Technologies Inc.
• LANDAUER
• Pacific Biosciences of California Inc.
• Digirad Corporation
• Berthold Technologies GmbH & Co.KG
• GENEWIZ IncIncom Inc.
• Lucerno Dynamics LLC
• Absolute Imaging Inc.
• Mediso Ltd.
• Ashby Gorman Baker Ltd.
• DDD-Diagnostic AS
• SurgicEye GmbH
• CMR Naviscan
What Are The Regional Insights Into The Whole Genome And Exome Sequencing Market?
North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
